48,466
edits
Difference between revisions of "Cancer antigen 125"
Jump to navigation
Jump to search
→Positive
(create) |
|||
| Line 6: | Line 6: | ||
==Positive== | ==Positive== | ||
*[[Serous carcinoma]]. | *[[Serous carcinoma]]. | ||
*[[Breast carcinoma]]. | |||
*[[Pancreatic ductal adenocarcinoma]].<ref name=pmid27093451>{{Cite journal | last1 = Jiang | first1 = K. | last2 = Tan | first2 = E. | last3 = Sayegh | first3 = Z. | last4 = Centeno | first4 = B. | last5 = Malafa | first5 = M. | last6 = Coppola | first6 = D. | title = Cancer Antigen 125 (CA125, MUC16) Protein Expression in the Diagnosis and Progression of Pancreatic Ductal Adenocarcinoma. | journal = Appl Immunohistochem Mol Morphol | volume = | issue = | pages = | month = Apr | year = 2016 | doi = 10.1097/PAI.0000000000000368 | PMID = 27093451 }}</ref> | |||
*[[Epithelioid sarcoma]] - reported.<ref name=pmid16740043>{{Cite journal | last1 = Lee | first1 = HI. | last2 = Kang | first2 = KH. | last3 = Cho | first3 = YM. | last4 = Lee | first4 = OJ. | last5 = Ro | first5 = JY. | title = Proximal-type epithelioid sarcoma with elevated serum CA 125: report of a case with CA 125 immunoreactivity. | journal = Arch Pathol Lab Med | volume = 130 | issue = 6 | pages = 871-4 | month = Jun | year = 2006 | doi = 10.1043/1543-2165(2006)130[871:PESWES]2.0.CO;2 | PMID = 16740043 }}</ref> | |||
==See also== | ==See also== | ||